Clinical Trials Logo

Nightmares clinical trials

View clinical trials related to Nightmares.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02506595 Completed - Nightmares Clinical Trials

A Trial of Treatment for Trauma-Related Nightmares in Active Duty Military Personnel

Start date: February 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to obtain preliminary data of the efficacy of Exposure, Relaxation, and Rescripting Therapy for nightmares among active duty military personnel.

NCT ID: NCT02199652 Completed - Clinical trials for Post Traumatic Stress Disorder

Reducing Suicidal Ideation Through Treatment of Nightmares-Post Traumatic Stress Disorder (PTSD)

REST-ON PTSD
Start date: March 2014
Phase: Phase 4
Study type: Interventional

Patients with PTSD, and frequent nightmares, and mild-moderate suicidal ideation, who are already taking a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI) will be randomized to either prazosin or placebo. The investigators hypothesize that patients receiving prazosin will have a greater reduction in suicidal ideation.

NCT ID: NCT01512771 Completed - Anxiety Clinical Trials

The Effect of Nasal Continuous Positive Airway Pressure Treatment on PTSD Symptoms.

PTSD
Start date: March 2010
Phase: N/A
Study type: Observational

We hypothesize that prevention of Sleep Disordered Breathing among PTSD patients with nasal CPAP will result improve their anxiety, insomnia and alcohol craving (among those who use alcohol to control their symptoms).

NCT ID: NCT01502930 Completed - Nightmares Clinical Trials

Treatment of Nightmares Via the Internet

MARI
Start date: January 2012
Phase: Phase 3
Study type: Interventional

This study is a randomized controlled trial (RCT) to evaluate the effect of an internet-based, guided self-help treatment of reoccurring and distressing nightmares. Imagery Rehearsal Therapy (IRT) will be compared to an active control treatment (CONT) and a recording-only group (REG). It is hypothesized that both active treatments will be superior to REG, and that IRT will be superior to CONT.

NCT ID: NCT01009112 Completed - Insomnia Clinical Trials

Treating Insomnia & Nightmares After Trauma: Impact on Symptoms & Quality of Life

Start date: January 2010
Phase: N/A
Study type: Interventional

Exposure to trauma, especially when it manifests as Posttraumatic Stress Disorder (PTSD), results in numerous negative consequences for patients, families, and society. Some of the most frequent, disturbing, and treatment resistant symptoms of PTSD are nightmares and insomnia. This study will examine whether treatments specifically targeted at those sleep disorders can improve clinical outcomes and increase health-related quality of life in individuals recently exposed to war-related trauma. Hypotheses are that treating nightmares and insomnia will improve both nighttime and daytime symptoms of PTSD, as well as quality of life.

NCT ID: NCT00691626 Completed - Clinical trials for Posttraumatic Stress Disorder

Cognitive Behavioral Therapy (CBT) for Nightmares in Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) Veterans

Start date: April 1, 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the effectiveness of two talk therapies for OEF/OIF Veterans at the Michael J. Crescenz and the West Haven VA Medical Centers. Participants will randomly receive one of two individual treatments intended to improve the sleep disturbance and nightmares of returning Veterans.

NCT ID: NCT00513045 Completed - Nightmares Clinical Trials

A Self-Help Method for Nightmares

Nightmares
Start date: April 2007
Phase: N/A
Study type: Interventional

The objective of this study is to validate a newly designed self-help treatment for nightmares. This self-help treatment is based on Imagery Rehearsal Therapy. This treatment will be validated in comparison to an exposure treatment a diary condition and a waiting list condition.

NCT ID: NCT00393874 Completed - Insomnia Clinical Trials

Efficacy of Sleep Interventions for Posttraumatic Stress Disorder (PTSD)

EASI-P
Start date: October 2006
Phase: N/A
Study type: Interventional

The purpose of this research study is to evaluate and compare the effects of experimental treatments aimed at improving insomnia and nightmares in men and women military veterans between the ages of 18 and 60 years old, and who have a condition called Posttraumatic Stress Disorder. Insomnia refers to difficulty falling or staying asleep, although enough time is allowed for sleeping. Insomnia is also associated with daytime consequences, such as lack of energy, irritability, and difficulty concentrating. Nightmares are bad dreams that may or may not awaken the sleeper, and that cause discomfort during the daytime. Chronic Posttraumatic Stress Disorder (PTSD) refers to symptoms that occur after someone experienced or witnessed a life-threatening event, and that persist for three months or more after the event. Symptoms include flashbacks, nightmares, feelings of detachment from others, sleep disturbances, irritability, anxiety, and efforts to avoid people and places associated with the life-threatening event. These symptoms occur after a life-threatening event. Symptoms that persist for more than one month indicate the presence of PTSD. In the present study, we will study people with chronic PTSD, which refers to PTSD symptoms that persist for more than 3 months. Efficacy of a treatment is defined as the capacity to produce the desired effects. In this study, we will evaluate and compare the capacity of two active experimental treatments to reduce insomnia and nightmares associated with PTSD, and one inactive intervention, called a placebo, for people who continue to have sleep difficulties despite receiving treatment with an antidepressant medication called a selective serotonin reuptake inhibitor (SSRI, like Prozac, Paxil, Zoloft, Celexa). The two active experimental treatments are a medication, prazosin, and a brief behavioral intervention, which involves exercises and techniques to reduce nightmares and improve sleep quality. Prazosin is an approved medication by the Food and Drug Administration (FDA) against high blood pressure, but is not FDA-approved for posttraumatic insomnia and nightmares.

NCT ID: NCT00291031 Completed - Anxiety Disorders Clinical Trials

Study of the Effect of Imagery Rehearsal Therapy (IRT) of Nightmares

Start date: February 2006
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine whether Imagery Rehearsal Therapy(IRT) is effective in the reduction of the number of nightmares and the nightmare distress in a population of patients with psychiatric disorders.